Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.19 USD | +11.00% | +24.61% | +1.94% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.94% | 1.25B | |
+23.64% | 48.09B | |
+46.90% | 40.62B | |
-2.65% | 40.43B | |
-6.20% | 28.36B | |
+8.50% | 24.89B | |
-20.03% | 19.01B | |
+28.93% | 12.09B | |
+0.01% | 11.88B | |
-0.78% | 11.8B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology : , GSK's Phase 3 Trial of COVID-19 Monoclonal Antibody Meets Primary Endpoint